EDB Investments — Full Portfolio
4 tracked investments · listed companies and verified rows first
Aspen Neuroscience develops iPSC-derived autologous cell therapies for neurological diseases, with a lead product (ANPD001) in Phase 1/2a clinical trials for Parkinson's disease.
BiotechDeep TechDigital HealthMedical DevicesSan Diego, US
Andrés Bratt-Leal(Co-Founder and Senior Vice President, Research & Development)inANDRÉS BRATT-LEAL, Ph.D.(Co-Founder; Senior Vice President, Research & Development)Damien McDevitt(President and Chief Executive Officer)inDAMIEN MCDEVITT, Ph.D.(President and Chief Executive Officer)
Co-investorsARCH Venture PartnersLifeforce CapitalOrbiMedDomain AssociatesSection 32Frazier Life Sciences+10 more
Mountain View, US
Jeffrey Haynie(Executive Officer, Director)Nolan Wright(Director)MIKE ASHER(Executive Officer)
BoardNavin Chadda(Director)John Occhipinti(Director)inLarry Augustin(Director)in
Co-investorsTransLink CapitalEbayMayfield FundPresidio VenturesRelay VenturesRembrandt Venture Partners+4 more
Contour Health is a senior care matching service that researches and calls senior care facilities on behalf of families, then provides a personalized shortlist of options based on medical needs, budget, and preferences.
Digital HealthHealthtechMarketplaces
Amitav M.(Founder)in
Co-investorsShine Capital
Mirxes develops RNA-based molecular diagnostics for early cancer detection, treatment selection, and multiomics research.
BiotechHealthtechMedical Devices
Co-investorsXeraya CapitalMitsui & Co
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.












